Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1991Science

Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4

View Full Paper
Ask AI
Bookmark
Share

Authors

PGPaul T. GolumbekWashington University in St. LouisALAudrey J. LazenbyUniversity of Nebraska Medical CenterHLHyam I. LevitskyCarisma Therapeutics (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Golumbek et al. (1991) studied this question.

synapsesocial.com/papers/6a11cbd4ed9c06332dfd39d3https://doi.org/10.1126/science.1948050
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes.1988 · 70 citations
  2. 2B-Cell Stimulatory Factor-1/Interleukin 41987 · 608 citations
  3. 3A Murine Renal Cell Carcinoma1973 · 147 citations
  4. 4Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors1988 · 1,092 citations
  5. 5Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody1979 · 1,124 citations